×
About 5,030 results

ALLMedicine™ Urinalysis Center

Research & Reviews  1,417 results

Incomplete bladder emptying and urinary tract infections after botulinum toxin injectio...
https://doi.org/10.1002/nau.24871
Neurourology and Urodynamics; Reynolds WS, Suskind AM et. al.

Jan 13th, 2022 - Onabotulinumtoxin A (BTX-A) is an effective therapy for overactive bladder (OAB), however, adverse events may prevent patients from initiating therapy. The study objective was to report real-world rates of incomplete emptying and urinary tract inf...

Pembrolizumab and Anlotinib in the Treatment of High-Grade Serous Ovarian Cancer
https://clinicaltrials.gov/ct2/show/NCT05188781

Jan 12th, 2022 - This is an open label Phase II study of anti-PD1 antibody pembrolizumab, in combination with anlotnib in patients with recurrent platinum sensitive, resistant or refractory. The study will enroll approximately 40 evaluable patients in total. Accru...

The Diagnostic Accuracy Of Procalcitonin for Urinary Tract Infection in Hospitalized Ol...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741546
Journal of General Internal Medicine; Choi JJ, McCarthy MW et. al.

Jan 9th, 2022 - The diagnosis of urinary tract infection (UTI) is challenging among hospitalized older adults, particularly among those with altered mental status. To determine the diagnostic accuracy of procalcitonin (PCT) for UTI in hospitalized older adults. W...

Uremia Workup
https://emedicine.medscape.com/article/245296-workup

Jan 6th, 2022 - Approach Considerations The diagnosis of renal failure is based primarily on an abnormal glomerular filtration rate (GFR) or abnormal creatinine clearance, which is usually evident due to an elevated serum creatinine level. Although assessment of ...

see more →

Guidelines  9 results

Microhematuria: AUA/SUFU Guideline.
https://doi.org/10.1097/JU.0000000000001297
The Journal of Urology; Barocas DA, Boorjian SA et. al.

Jul 24th, 2020 - Patients presenting with microhematuria represent a heterogeneous population with a broad spectrum of risk for genitourinary malignancy. Recognizing that patient-specific characteristics modify the risk of underlying malignant etiologies, this gui...

ACR Appropriateness Criteria® Hematuria.
https://doi.org/10.1016/j.jacr.2020.01.028
Journal of the American College of Radiology : JACR; , Wolfman DJ et. al.

May 7th, 2020 - Hematuria is a common reason for patients to be referred for imaging of the urinary tract. All patients diagnosed with hematuria should undergo a thorough history and physical examination, urinalysis, and serologic testing prior to any initial ima...

Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperpla...
https://doi.org/10.1111/iju.13401
International Journal of Urology : Official Journal of Th... Homma Y, Gotoh M et. al.

Jul 28th, 2017 - The present article is the abbreviated English translation of the Japanese guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia updated as of the end of 2016. The target patients are men aged >50 years complaining of l...

Best practice policy statement on urodynamic antibiotic prophylaxis in the non-index pa...
https://doi.org/10.1002/nau.23253
Neurourology and Urodynamics; Cameron AP, Campeau L et. al.

Mar 28th, 2017 - Antibiotic prophylaxis before urodynamic testing (UDS) is widely utilized to prevent urinary tract infection (UTI) with only limited guidance. The Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU) convened a Best...

Hematuria as a Marker of Occult Urinary Tract Cancer: Advice for High-Value Care From t...
https://doi.org/10.7326/M15-1496
Annals of Internal Medicine; Nielsen M, Qaseem A et. al.

Jan 27th, 2016 - The presence of blood in the urine, or hematuria, is a common finding in clinical practice and can sometimes be a sign of occult cancer. This article describes the clinical epidemiology of hematuria and the current state of practice and science in...

see more →

Drugs  27 results see all →

Clinicaltrials.gov  233 results

Pembrolizumab and Anlotinib in the Treatment of High-Grade Serous Ovarian Cancer
https://clinicaltrials.gov/ct2/show/NCT05188781

Jan 12th, 2022 - This is an open label Phase II study of anti-PD1 antibody pembrolizumab, in combination with anlotnib in patients with recurrent platinum sensitive, resistant or refractory. The study will enroll approximately 40 evaluable patients in total. Accru...

To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis
https://clinicaltrials.gov/ct2/show/NCT05135910

Jan 5th, 2022 - Primary Efficacy: To identify patients achieving Complete Cure in the target toenail at Week 52. Secondary Efficacy: To identify patients that have achieved 1) Clinical Cure, 2) Mycological Cure, and/or 3) Positive Response in the target toenail a...

Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)
https://clinicaltrials.gov/ct2/show/NCT04240210

Dec 20th, 2021 - With the advent of anti-retroviral therapy, HIV transformed into a manageable chronic disease for patients who were able to obtain medications, provided they could remain adherent to them. When single tablet regimens (STR) became available, adhere...

The Use of Memantine for Prevention of Alzheimer's Disease
https://clinicaltrials.gov/ct2/show/NCT05063851

Dec 17th, 2021 - The use of memantine for prevention of Alzheimer's Disease (AD) is designed to assess the feasibility of the use of memantine hydrochloride for prevention of AD and provide design elements for a Phase 3 efficacy study. Up to 128 subjects will be e...

Study of CAD-9303 in Subjects With Schizophrenia
https://clinicaltrials.gov/ct2/show/NCT04306146

Dec 15th, 2021 - This study will be conducted in two Parts. Part 1 will consist of Single Ascending Dose (SAD) cohorts that will be randomized, double-blind, and placebo-controlled to assess the safety, tolerability, and pharmacokinetics of CAD-9303. Part 2 will c...

see more →

News  274 results

72-year-old man • fever • new-onset urinary frequency • altered mental state • Dx?
https://www.mdedge.com/familymedicine/article/248466/infectious-diseases
MDedge Family Medicine; Tenzin Tsewang, MD, James Mayberry, MD et. al.

Nov 9th, 2021 - THE CASE A 72-year-old man was admitted to our Dallas hospital with a 4-day history of fevers and new-onset urinary frequency. He did not report any joint pain, sick contacts, or recent travel or recall any skin findings (rashes, insect bites).

Commercial Tests Offer Guidance in Bladder, Renal, Testicular Cancers
https://www.onclive.com/view/commercial-tests-offer-guidance-in-bladder-renal-testicular-cancers

Oct 6th, 2021 - Brian Rini, MD While biomarker-based tools designed to guide the diagnosis and treatment of prostate cancer are emerging at an extraordinarily rapid rate, they are not exploding in the same practice-changing way in all genitourinary cancers. The...

Iron Deficiency Anemia Clinical Practice Guidelines (BSG, 2021)
https://www.medscape.com/viewarticle/959843

Sep 29th, 2021 - Guidelines for the management of patients with iron deficiency anemia (IDA) in adults were published in September 2021 by the British Society of Gastroenterology (BSG) in Gut.[1] Assessment Before investigation, iron deficiency should be confirmed...

What Is the Most Likely Cause of This Patient's Fever?
https://www.medscape.com/viewarticle/956963

Aug 20th, 2021 - Dr Douglas Paauw A 63-year-old man undergoes cardiac bypass surgery. He is able to be extubated at 8 hours. The next morning he has a fever to 38.5°C His exam shows no redness at the surgical site, or at his IV sites. His lung exam is unremarkable...

Preprocedural Urinalyses Common but Often Not Indicated
https://www.medscape.com/viewarticle/956220

Aug 9th, 2021 - (Reuters Health) - Urinalyses are done within 30 days of 25% of common surgical procedures, and are not indicated in 89% of the cases, a U.S. study suggests. Researchers examined insurance claims data for 13.2 million inpatient and outpatient proc...

see more →

Patient Education  52 results see all →